pharmaspectra topco ltd
pharmaspectra topco ltd Company Information
Company Number
12125137
Website
-Registered Address
3 forbury place, 23 forbury road, reading, RG1 3JH
Industry
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Telephone
-
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
iqvia ltd. 100%
pharmaspectra topco ltd Estimated Valuation
Pomanda estimates the enterprise value of PHARMASPECTRA TOPCO LTD at £0 based on a Turnover of £0 and 1.21x industry multiple (adjusted for size and gross margin).
pharmaspectra topco ltd Estimated Valuation
Pomanda estimates the enterprise value of PHARMASPECTRA TOPCO LTD at £0 based on an EBITDA of £-2.2m and a 4.58x industry multiple (adjusted for size and gross margin).
pharmaspectra topco ltd Estimated Valuation
Pomanda estimates the enterprise value of PHARMASPECTRA TOPCO LTD at £0 based on Net Assets of £-382.3k and 1.71x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pharmaspectra Topco Ltd Overview
Pharmaspectra Topco Ltd is a live company located in reading, RG1 3JH with a Companies House number of 12125137. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in July 2019, it's largest shareholder is iqvia ltd. with a 100% stake. Pharmaspectra Topco Ltd is a young, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Pharmaspectra Topco Ltd Health Check
There is insufficient data available to calculate a health check for Pharmaspectra Topco Ltd. Company Health Check FAQs
0 Strong
0 Regular
2 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Pharmaspectra Topco Ltd
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Pharmaspectra Topco Ltd
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Pharmaspectra Topco Ltd
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Pharmaspectra Topco Ltd
- - Industry AVG
Employees
with 1 employees, this is below the industry average (106)
- Pharmaspectra Topco Ltd
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Pharmaspectra Topco Ltd
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Pharmaspectra Topco Ltd
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Pharmaspectra Topco Ltd
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Pharmaspectra Topco Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Pharmaspectra Topco Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Pharmaspectra Topco Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 122.2%, this is a higher level of debt than the average (69.9%)
- - Pharmaspectra Topco Ltd
- - Industry AVG
PHARMASPECTRA TOPCO LTD financials
Pharmaspectra Topco Ltd's latest turnover from December 2022 is 0 and the company has net assets of -£382.3 thousand. According to their latest financial statements, we estimate that Pharmaspectra Topco Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|
| Turnover | 0 | 11,498,630 | 9,972,025 |
| Other Income Or Grants | 0 | 0 | |
| Cost Of Sales | 4,799,701 | 4,804,212 | |
| Gross Profit | 6,698,929 | 5,167,812 | |
| Admin Expenses | 15,096,438 | 24,921,892 | |
| Operating Profit | -2,221,047 | -8,397,509 | -19,754,080 |
| Interest Payable | 0 | 6,862,145 | 7,650,355 |
| Interest Receivable | 172,854 | 0 | 221 |
| Pre-Tax Profit | -2,048,193 | -15,259,654 | -27,404,213 |
| Tax | 0 | 3,042,312 | 1,794,154 |
| Profit After Tax | -2,048,193 | -12,217,342 | -25,610,059 |
| Dividends Paid | 0 | 0 | 0 |
| Retained Profit | -2,048,193 | -12,217,342 | -25,610,059 |
| Employee Costs | 0 | 5,723,384 | 5,810,543 |
| Number Of Employees | 275 | 209 | |
| EBITDA* | -2,221,047 | -2,063,322 | -9,840,263 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|
| Tangible Assets | 0 | 137,048 | 112,396 |
| Intangible Assets | 0 | 19,974,271 | 32,703,496 |
| Investments & Other | 1,723,904 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 |
| Total Fixed Assets | 1,723,904 | 20,111,320 | 32,815,892 |
| Stock & work in progress | 0 | 0 | 0 |
| Trade Debtors | 0 | 5,511,238 | 4,262,388 |
| Group Debtors | 0 | 0 | 0 |
| Misc Debtors | 0 | 13,948,347 | 2,364,737 |
| Cash | 0 | 470,357 | 253,787 |
| misc current assets | 0 | 0 | 0 |
| total current assets | 0 | 19,929,944 | 6,880,913 |
| total assets | 1,723,904 | 40,041,264 | 39,696,804 |
| Bank overdraft | 0 | 773,055 | 781,237 |
| Bank loan | 0 | 0 | 0 |
| Trade Creditors | 0 | 3,003,374 | 1,332,661 |
| Group/Directors Accounts | 2,106,224 | 0 | 0 |
| other short term finances | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 |
| other current liabilities | 0 | 11,437,483 | 7,904,884 |
| total current liabilities | 2,106,224 | 15,213,913 | 10,018,783 |
| loans | 0 | 61,283,389 | 53,909,223 |
| hp & lease commitments | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 |
| total long term liabilities | 0 | 61,283,390 | 53,909,223 |
| total liabilities | 2,106,224 | 76,497,303 | 63,928,006 |
| net assets | -382,320 | -36,456,039 | -24,231,202 |
| total shareholders funds | -382,320 | -36,456,039 | -24,231,202 |
| Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|
| Operating Activities | |||
| Operating Profit | -2,221,047 | -8,397,509 | -19,754,080 |
| Depreciation | 0 | 70,257 | 65,533 |
| Amortisation | 0 | 6,263,930 | 9,848,284 |
| Tax | 0 | 3,042,312 | 1,794,154 |
| Stock | 0 | 0 | 0 |
| Debtors | -19,459,586 | 12,832,461 | 6,627,125 |
| Creditors | -3,003,374 | 1,670,713 | 1,332,661 |
| Accruals and Deferred Income | -11,437,483 | 3,532,599 | 7,904,884 |
| Deferred Taxes & Provisions | 0 | 0 | 0 |
| Cash flow from operations | 2,797,682 | -6,650,159 | -5,435,689 |
| Investing Activities | |||
| capital expenditure | 0 | 0 | |
| Change in Investments | 1,723,904 | 0 | 0 |
| cash flow from investments | 0 | 0 | |
| Financing Activities | |||
| Bank loans | 0 | 0 | 0 |
| Group/Directors Accounts | 2,106,224 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 |
| Long term loans | -61,283,389 | 7,374,166 | 53,909,223 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 |
| share issue | |||
| interest | 172,854 | -6,862,145 | -7,650,134 |
| cash flow from financing | -20,882,399 | 504,526 | 47,637,946 |
| cash and cash equivalents | |||
| cash | -470,357 | 216,570 | 253,787 |
| overdraft | -773,055 | -8,182 | 781,237 |
| change in cash | 302,698 | 224,752 | -527,450 |
pharmaspectra topco ltd Credit Report and Business Information
Pharmaspectra Topco Ltd Competitor Analysis
Perform a competitor analysis for pharmaspectra topco ltd by selecting its closest rivals and benchmarking them against 12 key performance metrics.
pharmaspectra topco ltd Ownership
PHARMASPECTRA TOPCO LTD group structure
Pharmaspectra Topco Ltd has 1 subsidiary company.
Ultimate parent company
IQVIA HOLDINGS INC
#0013898
2 parents
PHARMASPECTRA TOPCO LTD
12125137
1 subsidiary
pharmaspectra topco ltd directors
Pharmaspectra Topco Ltd currently has 2 directors. The longest serving directors include Mr Robert Kotchie (Aug 2022) and Mr Graham Park (Aug 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Robert Kotchie | United Kingdom | 45 years | Aug 2022 | - | Director |
| Mr Graham Park | United Kingdom | 49 years | Aug 2022 | - | Director |
P&L
December 2022turnover
0
-100%
operating profit
-2.2m
-74%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
-382.3k
-0.99%
total assets
1.7m
-0.96%
cash
0
-1%
net assets
Total assets minus all liabilities
Similar Companies
pharmaspectra topco ltd company details
company number
12125137
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
incorporation date
July 2019
age
5
accounts
Full Accounts
ultimate parent company
previous names
N/A
incorporated
UK
address
3 forbury place, 23 forbury road, reading, RG1 3JH
last accounts submitted
December 2022
pharmaspectra topco ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to pharmaspectra topco ltd. Currently there are 0 open charges and 1 have been satisfied in the past.
pharmaspectra topco ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
